The role of ELF3 in acquired resistance to endocrine therapy in ER-positive breast cancer

被引：0
|
作者：
Zhang, Na
Zheng, Rongbin
Brown, Myles
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-3894
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3894
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Neoadjuvant endocrine therapy: A potential strategy for ER-positive breast cancer
    Li-Tong Yao
    Mo-Zhi Wang
    Meng-Shen Wang
    Xue-Ting Yu
    Jing-Yi Guo
    Tie Sun
    Xin-Yan Li
    Ying-Ying Xu
    [J]. World Journal of Clinical Cases, 2019, (15) : 1937 - 1953
  • [2] ER and PI3K Independently Modulate Endocrine Resistance in ER-Positive Breast Cancer
    Van Tine, Brian A.
    Crowder, Robert J.
    Ellis, Matthew J.
    [J]. CANCER DISCOVERY, 2011, 1 (04) : 287 - 288
  • [3] Neoadjuvant endocrine therapy: A potential strategy for ER-positive breast cancer
    Yao, Li-Tong
    Wang, Mo-Zhi
    Wang, Meng-Shen
    Yu, Xue-Ting
    Guo, Jing-Yi
    Sun, Tie
    Li, Xin-Yan
    Xu, Ying-Ying
    [J]. WORLD JOURNAL OF CLINICAL CASES, 2019, 7 (15) : 1937 - 1953
  • [4] Towards Precision Radiation Oncology: Endocrine Therapy Resistance as a Biomarker for Radiation Resistance in ER-Positive Breast Cancer
    Udden, S. M. Nashir
    Rahimi, Asal
    Kim, Dong W. Nathan
    Alluri, Prasanna
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [5] HAS2-Ezrin-ER axis plays a role in acquired antiestrogen resistance of ER-positive breast cancer
    Sun, Xiaodan
    Tang, Fen
    Guo, Qian
    Liu, Yiwen
    He, Yiqing
    Du, Yan
    Gao, Feng
    Zhang, Guoliang
    Yang, Cuixia
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [6] Aberrant Regulation of RAD51 Promotes Resistance of Neoadjuvant Endocrine Therapy in ER-positive Breast Cancer
    Yan Jia
    Yueshuai Song
    Guolei Dong
    Chunfang Hao
    Weipeng Zhao
    Shufen Li
    Zhongsheng Tong
    [J]. Scientific Reports, 9
  • [7] ER-positive breast cancer cells are poised for RET-mediated endocrine resistance
    Horibata, Sachi
    Rice, Edward J.
    Mukai, Chinatsu
    Marks, Brooke A.
    Sams, Kelly
    Zheng, Hui
    Anguish, Lynne J.
    Coonrod, Scott A.
    Danko, Charles G.
    [J]. PLOS ONE, 2018, 13 (04):
  • [8] Aberrant Regulation of RAD51 Promotes Resistance of Neoadjuvant Endocrine Therapy in ER-positive Breast Cancer
    Jia, Yan
    Song, Yueshuai
    Dong, Guolei
    Hao, Chunfang
    Zhao, Weipeng
    Li, Shufen
    Tong, Zhongsheng
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [9] Primary endocrine therapy vs chemotherapy in postmenopausal ER-positive breast cancer patients
    不详
    [J]. EJC SUPPLEMENTS, 2006, 4 (02): : 117 - 117
  • [10] Endocrine therapy for ER-positive/HER2-negative metastatic breast cancer
    Reinert, Tomas
    de Paula, Bruno
    Shafaee, Maryam Nemati
    Souza, Pedro Henrique
    Ellis, Matthew J.
    Bines, Jose
    [J]. CHINESE CLINICAL ONCOLOGY, 2018, 7 (03)
12345